Here’s Why You Should Trade Today’s Vaccine News Differently…

Another Monday, another bit of good news from a Covid vaccine trial. It’s Groundhog Day – over and over (Could JNJ news be up next Monday?).

This time it was AstraZeneca plc (AZN) that released preliminary data on the vaccine against Covid-19 that it’s been working on with Oxford University. Unlike Pfizer Inc.’s (PFE) and Moderna Inc.’s (MRNA) two vaccines that scored around 95% and 94.5% efficacy rates, AstraZeneca’s has an efficacy of about 70%. The AZN vaccine does have some distribution benefits since it requires only standard refrigeration.

If anything, this latest bit of news is even more impressive than what we’ve seen before. Pfizer and Moderna used new mRNA technology to get vaccines for Covid-19 out in record time.

Meanwhile, AstraZeneca and Oxford University used existing vaccine technology to make a vaccine in under a year, rather than the several years it usually takes. So did Johnson & Johnson (JNJ), which should be announcing its preliminary results soon as well.

Why 2021 Could Give You Massive Profit Windfalls

Over the last two weeks, as not one but two different Covid-19 vaccine candidates have reported incredible efficacy that few could have even dared to hope for so quickly, the market has turned its bullish stance into hyper drive.

Yesterday, I made an appearance on Fox Business’ Varney & Co. to discuss the stampede of bulls we’re seeing towards the end of this year and whether or not that momentum is likely to carry over into the new year.

Obviously getting more and more of the population inoculated against Covid-19 will do wonders for the economy and market in 2021, but that’s not the only reason I’m bullish as we put 2020 in the rearview mirror.

Check out the recording below to learn what else is going to continue to drive markets up. I’ll also show you why Walmart Inc. (WMT) is one of my favorite buys right now.

Click below to watch

View this page online: